Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer

por Gan, Junqing, Meng, Qingwei, Li, Yanjing
Publicado 2020

Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer

por Gan, Junqing, Meng, Qingwei, Li, Yanjing
Publicado 2021

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer

por Jiao, Zonglin, Feng, Xiao, Cui, Yuqing, Wang, Lei, Gan, Junqing, Zhao, Yanbin, Meng, Qingwei
Publicado 2022

Pyroptosis, a new bridge to tumor immunity

por Li, Lisha, Jiang, Mingxia, Qi, Ling, Wu, Yiming, Song, Dongfeng, Gan, Junqing, Li, Yanjing, Bai, Yuxian
Publicado 2021

MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation

por Gan, Junqing, Zhang, Yu, Liu, Shan, Mu, Guannan, Zhao, Juan, Jiang, Wei, Li, Jiade, Li, Qi, Wu, Yangjiazi, Wang, Xinling, Che, Dehai, Li, Xiaomei, Huang, Xiaoyi, Meng, Qingwei
Publicado 2023

MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis

por Gan, Junqing, Liu, Shan, Zhang, Yu, He, Liangzi, Bai, Lu, Liao, Ran, Zhao, Juan, Guo, Madi, Jiang, Wei, Li, Jiade, Li, Qi, Mu, Guannan, Wu, Yangjiazi, Wang, Xinling, Zhang, Xingli, Zhou, Dan, Lv, Huimin, Wang, Zhengfeng, Zhang, Yanqiao, Qian, Cheng, Feng, MeiYan, Chen, Hui, Meng, Qingwei, Huang, Xiaoyi
Publicado 2022